📚 Lecture Overview
This lecture covers Systemic Sclerosis (Scleroderma), a chronic inflammatory autoimmune disease characterized by widespread vascular dysfunction and excessive fibrosis affecting the skin and internal organs. Mastering this material is critical for recognizing early clinical signs, differentiating disease subtypes, and managing life-threatening complications like renal crisis and pulmonary hypertension.
🎯 Key Concepts & Definitions
- Systemic Sclerosis (SSc): A chronic inflammatory autoimmune disease affecting mainly the skin and vascular system, with potential involvement of internal organs.
- SSc Sine Scleroderma: A rare form affecting internal body organs without skin involvement, which carries a particularly bad prognosis.
- Raynaud's Phenomenon (RP): An exaggerated vascular response to cold or stress showing triphasic color changes (pallor, cyanosis, redness).
- CREST Syndrome: A limited subset of scleroderma characterized by Calcinosis, Raynaud's phenomenon, Esophageal dysmotility, Sclerodactyly, and Telangiectasia.
- Scleroderma Renal Crisis (SRC): A life-threatening complication marked by acute-onset oliguric renal failure and malignant hypertension, representing the 2nd cause of death.
- Modified Rodnan Skin Score (mRss): A semiquantitative clinical scoring system ranging from 0 to 51 used to assess the extent and severity of skin thickening.
📖 Main Content
1. Epidemiology and Risk Factors
- Demographics: Female to male ratio is 4:1, with onset most common in the 4th and 5th decades of life.
- Non-infectious Triggers: Exposure to silica, coal, gold, vibration machines, industrial solvents (trichloroethane, paint, vinyl chloride), and toxic rapeseed oil.
- Drugs Associated: Bleomycin, cocaine, ergot, arsenic, nonselective beta blockers, and tryptans.
2. Pathogenesis & Immunological Mechanisms
- Genetic predisposition combined with environmental factors stimulates T cells, B cells, macrophages, mast cells, and fibroblasts.
- Inflammatory cytokines (IL-4, IL-6, TGF-beta, PDGF, and CTGF) are released, leading to increased production of collagen types I, III, V, and VII, proteoglycans, and fibronectin.
- Vascular dysfunction is driven by VEGF and anti-endothelial cell antibodies, causing structural scarring and ischemia.
3. Classification: Limited vs. Diffuse Sclerosis
- Limited Scleroderma (lcSSc):
- Skin thickening is distal to the elbows and knees, sparing the trunk.
- Perioral skin thickening causes pursing of the lips.
- Associated with CREST syndrome and Anti-centromere antibodies.
- Raynaud's phenomenon occurs long before skin changes appear.
- Diffuse Scleroderma (dcSSc):
- Skin thickening extends proximal to the elbows and knees, involving the trunk.
- Higher likelihood of internal organ involvement.
- Pulmonary fibrosis and Scleroderma Renal Crisis are much more common.
- Associated with Anti-scl-70 (anti-topoisomerase I) and Anti-RNA polymerase III antibodies.
4. Major Systemic Manifestations
- Vascular: Pulmonary hypertension is the 1st cause of death. Digital ulcers and Raynaud's phenomenon are hallmark signs.
- Renal: Scleroderma Renal Crisis (SRC) is the 2nd cause of death. Managed urgently with ACE inhibitors. Risk factors include rapid skin thickening within the first 2-3 years and steroid use (>15mg/day of prednisolone).
- Gastrointestinal: Esophageal hypomotility leads to severe GERD, dysphagia, Barrett esophagus, and bacterial overgrowth from small intestinal malabsorption.
- Musculoskeletal: Tendon friction rubs carry a bad prognosis and indicate aggressive internal organ involvement. Joint destruction is rare unless an overlap with rheumatoid arthritis exists.
5. Autoantibody Profiles
- Anti-centromere: Highly specific for limited systemic sclerosis.
- Anti-Scl-70 (Anti-topoisomerase I): Associated with diffuse disease and pulmonary fibrosis.
- Anti-RNA Polymerase III: Strongly associated with diffuse skin involvement and high risk of Scleroderma Renal Crisis.
- Anti-PM/Scl: Seen in overlap syndromes with polymyositis.
📊 Visual Learning
flowchart TD
A[Systemic Sclerosis] --> B[Limited lcSSc]
A --> C[Diffuse dcSSc]
B --> D[CREST Syndrome]
B --> E[Anti-centromere Ab]
C --> F[Trunk Skin Involvement]
C --> G[Renal Crisis Risk]
C --> H[Anti-Scl-70 Ab]
mindmap
root("Systemic Sclerosis Complications")
"Vascular"
"Pulmonary Hypertension"
"Raynaud Phenomenon"
"Digital Ulcers"
"Renal"
"Renal Crisis"
"Malignant HTN"
"Oliguric Failure"
"Gastrointestinal"
"GERD and Strictures"
"Barrett Esophagus"
"Bacterial Overgrowth"
"Pulmonary"
"Interstitial Lung Disease"
"Cor Pulmonale"
graph LR
A[Cold or Stress] --> B[Pallor Vasospasm]
B --> C[Cyanosis Deoxygenation]
C --> D[Redness Rewarming]
💡 Important Points to Remember
- Leading Causes of Death: Pulmonary hypertension is the number one cause of death, followed by Scleroderma Renal Crisis as the number two cause.
- Renal Crisis Trap: High-dose corticosteroids (>15mg/day of prednisolone) are a major risk factor precipitating Scleroderma Renal Crisis.
- Antibody Correlation: Anti-centromere points to limited disease; Anti-Scl-70 and Anti-RNA polymerase III point to diffuse disease.
- Tendon Friction Rubs: Audible or palpable deep tendon friction rubs indicate aggressive disease and a high risk of internal organ damage.
- Raynaud's Triphasic Color Change: Remember the sequence: Pallor (vasospasm) $\rightarrow$ Cyanosis (deoxygenated blood) $\rightarrow$ Redness (reactive hyperemia/vasodilation).
- Skin Scoring: The modified Rodnan Skin Score (mRss) evaluates 17 body areas on a scale of 0 to 3, giving a total possible score range of 0 to 51.
- Gastrointestinal Complications: Esophageal hypomotility leads to severe GERD, which can progress to Barrett esophagus and esophageal cancer.
- Digital Ulcers Management: Treated using endothelin receptor antagonists (such as bosentan) and atorvastatin.
⚠️ Common Exam Questions
- MCQ Trick: Examiners frequently ask about the primary cause of death in systemic sclerosis. Students often confuse renal crisis with pulmonary hypertension; remember that pulmonary hypertension is the 1st cause of death, while renal crisis is the 2nd.
- The Steroid Trap: Questions will feature a patient with rapidly progressive diffuse skin changes who is started on high-dose corticosteroids, followed by a sudden spike in blood pressure and oliguria. Examiners use this to test your knowledge that high-dose steroids trigger Scleroderma Renal Crisis.
- Antibody Matching: Matching autoantibodies (Anti-centromere vs. Anti-Scl-70) to limited and diffuse subtypes is a high-yield exam favorite.
- Short-Answer Scenarios: Expect clinical vignettes describing triphasic digital color changes (Raynaud's) or fingertip pitting scars, asking for the underlying vascular diagnosis and associated autoantibodies.
📝 Quick Review Checklist
I can explain the pathogenesis and cytokine pathways of systemic sclerosis
I understand the clinical differences between limited and diffuse subtypes
I can define CREST syndrome and list its five components
I know how to recognize and manage Scleroderma Renal Crisis
I can match autoantibodies (Anti-centromere, Anti-Scl-70, Anti-RNA polymerase III) to their disease features
I understand the triphasic color changes of Raynaud's phenomenon
I know the leading causes of death in systemic sclerosis
I can describe the use of the modified Rodnan skin score (mRss)